Jessica Chubak, PhD, is an epidemiologist who works to improve cancer diagnosis, treatment, control, and survivorship. She contributes to several national collaborations that are finding practical, efficient, effective ways to screen for cancer, especially colorectal cancer. She also studies how common medications affect cancer risk and recurrence. Intrigued by how pets positively affect health, Dr. Chubak is studying animal-assisted activities in clinics and hospitals where children get treated for cancer. Dr. Chubak’s methodological research focuses on the use of administrative and electronic health record data in epidemiologic and health services studies.
Dr. Chubak joined KPWHRI in 2007, bringing expertise in epidemiologic methods, pharmacoepidemiology, and cancer. Awarded a Fulbright graduate student grant, Dr. Chubak pursued her master's degree in bioethics and health law in New Zealand before completing her PhD in Epidemiology at the University of Washington (UW). Dr. Chubak is an affiliate associate professor in the Department of Epidemiology at the UW School of Public Health, where she enjoys guest-lecturing and getting to work with students.
Epidemiology; colorectal cancer; medication use; survivorship; recurrence; secondary prevention; quality of life; automated data collection; screening; animal-assisted activities; survivorship
Screening
Cancer risk and use of common medications
Chubak J, Lund JL. Noncancer comparators in cancer survivorship studies. Cancer. 2022 May 3. doi: 10.1002/cncr.34253. Online ahead of print. PubMed
Liu X, Chubak J, Hubbard RA, Chen Y. SAT: a Surrogate-Assisted Two-wave case boosting sampling method, with application to EHR-based association studies. J Am Med Inform Assoc. 2021 Dec 28:ocab267. doi: 10.1093/jamia/ocab267. [Epub ahead of print]. PubMed
Haas JS, Cheng D, Yu L, Atlas SJ, Clark C, Feldman S, Silver MI, Kamineni A, Chubak J, Pocobelli G, Tiro JA, Kobrin SC. Variation in the receipt of human papilloma virus co-testing for cervical screening: individual, provider, facility and healthcare system characteristics. Prev Med. 2022 Jan;154:106871. doi: 10.1016/j.ypmed.2021.106871. Epub 2021 Nov 8. PubMed
Zhu Y, Hubbard RA, Chubak J, Roy J, Mitra N. Core concepts in pharmacoepidemiology: violations of the positivity assumption in the causal analysis of observational data: consequences and statistical approaches. Pharmacoepidemiol Drug Saf. 2021 Nov;30(11):1471-1485. doi: 10.1002/pds.5338. Epub 2021 Aug 24. PubMed
Sarma EA, Thompson MJ, Bowles EA, Burnett-Hartman AN, Hubbard RA, Yu O, Chubak J. Patient and tumor characteristics of screening-age adults diagnosed with screen-detected versus symptomatic colon cancer. Colorectal Dis. 2022 Jun 23. doi: 10.1111/codi.16232. Online ahead of print. PubMed
Beatty JD, Sun Q, Markowitz D, Chubak J, Huang B, Etzioni R. Identifying breast cancer recurrence histories via patient-reported outcomes. J Cancer Surviv. 2021 Apr 14. doi: 10.1007/s11764-021-01033-7. [Epub ahead of print]. PubMed
Hubbard RA, Lett E, Ho GYF, Chubak J. Characterizing bias due to differential exposure ascertainment in electronic health record data. Health Serv Outcomes Res Methodol. 2021;21(3):309-323. doi: 10.1007/s10742-020-00235-3. Epub 2021 Jan 4. PubMed
Understanding emergency department use among adolescent and young adult cancer survivors can help address care gaps.
How KPWHRI is contributing to better cancer screening and better outcomes for patients.
Top pediatric oncology hospitals reported lasting changes to programs involving visits with animals.